(1-(Oxetan-3-yl)-1H-pyrazol-4-yl)boronic acid

Catalog No.: 
ACBAOR275
CAS No.: 
2226987-43-3
Molecular Formula: 
C6H9BN2O3
Molecular Weight: 
167.96
(1-(Oxetan-3-yl)-1H-pyrazol-4-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$443.00InquiryInquiry
100mg97%$584.00InquiryInquiry
250mg97%$897.00InquiryInquiry
1g97%$1449.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-(Oxetan-3-yl)-1H-pyrazol-4-yl)boronic acid
IUPAC Name(1-(Oxetan-3-yl)-1H-pyrazol-4-yl)boronic acid
MDL No.MFCD28098655
Molecular FormulaC6H9BN2O3
Molecular Weight167.96
SMILESOB(C1=CN(C2COC2)N=C1)O
InChI KeyDLMPXRKLZGBYIT-UHFFFAOYSA-N
SynonymBoronic acid, B-[1-(3-oxetanyl)-1H-pyrazol-4-yl]-;1-(Oxetan-3-yl)-1H-pyrazole-4-boronic Acid
CAS No.2226987-43-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACBAOR275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKBRD053 route compound structure diagram
    ACKBRD05339267-79-3In Stock
  2. Plus
  3. ACRCWX846 route compound structure diagram
    ACRCWX846763120-58-7In Stock
  4. Then
  5. ACBAOR275 route product structure diagram
    ACBAOR2752226987-43-3
Inquiry

2. ACBAOR275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWBXE867 route compound structure diagram
    ACWBXE8671339890-99-1In Stock
  2. Then
  3. ACBAOR275 route product structure diagram
    ACBAOR2752226987-43-3
Inquiry

3. ACBAOR275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBAOR275 route product structure diagram
    ACBAOR2752226987-43-3
Inquiry

Comments (0)